Back to search
FDAFDA · Food and drugs·Recall number D-1112-2018

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

Published August 29, 2018 · Recall initiated: August 14, 2018

Summary

FDA records drug Class III recall D-1112-2018, published August 29, 2018 and initiated August 14, 2018. Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Status: Terminated; Reported quantity: 408 cartons; Lot: Batch 3096049. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Distributor
Nationwide USA
Lot
Batch 3096049
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08 recalled?

Yes. FDA published recall D-1112-2018 on August 29, 2018. Reported hazard: Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

What should I do if I have this product?

Voluntary: Firm initiated · Letter